This site is intended for health professionals only

Announcement by Lundbeck

teaser

H Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H Lundbeck A/S from the company’s executives today or yesterday.

Name:
Per Wold-Olsen

Job position of the executive:
Chairman of Supervisory Board

ID code (ISIN code):
DK 0010287234 / CUSIP 40422M107

Description of the security:
ADR

Nature of the transaction:
Purchase of ADR

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Date of trading:
6 March 2009

Market on which the trading was effected:
Pink Sheets Level 1 / unsponsored program

Number of traded securities:
10,000 ADR

Market price of securities traded:
1,021,300.00 DKK

Persons/entities under an obligation to report
Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

  • spouse or cohabitant
  • children below the age of 18
  • legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group’s financial result for 2009.

Lundbeck






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x